2018
DOI: 10.2147/ndt.s174552
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome

Abstract: PurposeThe purpose of this study was to examine alexithymia among restless legs syndrome (RLS) patients, compare with healthy controls, and argue the clinical inferences of this relationship. We searched for anxiety and depression and their clinical outcomes among patients and searched whether the results are similar to previous studies.Patients and methodsEighty-seven RLS patients and 88 age, gender, and educationally matched healthy controls were assessed in Bezmialem Foundation University Hospital. RLS pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
6

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(17 citation statements)
references
References 55 publications
0
11
6
Order By: Relevance
“…However, the mean scores in the AUG group (>50) almost reached the established cut off score for borderline alexithymia (≥52), and borderline alexithymia scores were previously linked with emotion dysregulation, impulsivity, and aggression 33 . Furthermore, and in contrast to a previous study, 34 we did not find a significant difference on the TAS‐20 scores between RLS patients without augmentation and healthy controls. It is possible that a subgroup of patients in the previous study by Yilmaz et al 34 had augmentation or ICD symptoms which may have influenced their results.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…However, the mean scores in the AUG group (>50) almost reached the established cut off score for borderline alexithymia (≥52), and borderline alexithymia scores were previously linked with emotion dysregulation, impulsivity, and aggression 33 . Furthermore, and in contrast to a previous study, 34 we did not find a significant difference on the TAS‐20 scores between RLS patients without augmentation and healthy controls. It is possible that a subgroup of patients in the previous study by Yilmaz et al 34 had augmentation or ICD symptoms which may have influenced their results.…”
Section: Discussioncontrasting
confidence: 99%
“…Furthermore, and in contrast to a previous study, 34 we did not find a significant difference on the TAS‐20 scores between RLS patients without augmentation and healthy controls. It is possible that a subgroup of patients in the previous study by Yilmaz et al 34 had augmentation or ICD symptoms which may have influenced their results.…”
Section: Discussioncontrasting
confidence: 99%
“…Our study, in contrast to the studies above, does not show similar results that may indicate any impairment of QOL amongst RLS patients on hemodialysis. Even though Yilmaz et al ascertained that depression and anxiety co-existed in RLS [23], we failed to establish any signi cant correlation.…”
Section: Discussioncontrasting
confidence: 82%
“…[ 2 3 4 ] Studies show that RLS frequently interrupts patients’ sleep, causes insomnia, associates with hypertension, cardiovascular diseases, and cerebrovascular diseases, triggers anxiety and depression, thus impairs the quality of life. [ 5 6 7 8 9 10 ] Currently, dopamine agonist medications such as pramipexole, ropinirole, and rotigotine have been approved by the US Food and Drug Administration to treat RLS; however, their side effects, including sleepiness, dizziness, or augmentation during medication, reduce their compliance. [ 11 12 ]…”
Section: Introductionmentioning
confidence: 99%